First Patient Dosed in Phase 1 Clinical Study of Tafasitamab in Firstline DLBCL
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / December 27, 2019 / MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:MOR) today...
Day: December 27, 2019
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / December 27, 2019 / MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:MOR) today...